The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are worried by the “tsunami of future cancer cases that will drain our health systems and our economies”, and call [more]
The song is captivating, with professional music and arrangements. The voices are those of the teenage patients of the pediatric unit of Milan’s Istituto Nazionale dei Tumori who worked for several months to record a [more]
Journalists from India, Germany, France, Pakistan and Syria have been recognised for their outstanding achievement in the 2018 Cancer Journalism Award, organised by Cancer World magazine. A remarkable 181 entries produced in 2017 and 2018 [more]
The website of the US National Guideline Clearinghouse, that currently makes available 359 guidelines related to oncology, will be closed in mid-July, for lack of federal funding: “The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web [more]
At the just concluded Uppsala Health Summit in Sweden, the Member of the Swedish Parliament Maria Weimer talked about breast cancer from the perspective of a young woman survivor, and I listened to her with [more]
Prof. Dr. Agim Sallaku was born in Tirana, Albania in 1956. He received his medical degree from the Faculty of Medicine at the University of Tirana in 1981 and in the same year he started [more]
My good friend Professor Richard Sullivan wrote an excellent piece for Cancer World on how to reverse the decline in the benefit per cost of cancer interventions. It gave me food for thought. Sullivan gave [more]
It’s called CancerSEEK the first experimental noninvasive blood test that could screen eight different cancers and localize their source. It was developed by an international research team based at Johns Hopkins University in Baltimore, USA. [more]
Acupuncture and cognitive behavioral therapy for insomnia (CBT-I) can improve insomnia severity beyond traditional medicine, and have lasting effects, according to a study – funded by the Patient-Centered Outcomes Research Institute (PCORI) – that will [more]
A n estimated 50,000 people who die from cancer every year could still be alive if the quality of diagnosis and care in European countries with the poorest survival rates were as good as the median [more]
After 25 years of trying to improve the way we organise and deliver cancer care we now have a fairly clear idea about what changes are needed to get the best patient outcomes. Finding ways [more]
Patients play an integral part in the clinical trial process that enables new treatments to be approved and adopted into clinical practice. Without patients, no trials can be undertaken, and thus no drugs can be [more]
A spate of recent studies suggest that differences in population of bacteria and other micro-organisms that inhabit our intestines may be a key factor differentiating between people who respond to immune checkpoint inhibitors and those [more]